Project Number 1K99AG076739-01 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Cis proline directed proteotoxicity in the early development and therapy oftraumatic brain injury and vascular dementia Research Categorization Primary Disease / Condition Vascular Dementia/Dysfunction CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 2. Tau b. Tau Phosphorylation, Metabolism, and Assembly Category F. Research Resources 3. Professional and Career Development c. Career Development Researcher and Organization Principal Investigator QIU, CHENXI Principal Investigator First Name CHENXI Principal Investigator Last Name QIU Awardee Organization HARVARD MEDICAL SCHOOL Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PA-20-188: NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) FY Overall Cost $109,906 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official OPANASHUK, LISA A
